https://www.selleckchem.com/pr....oducts/mk-8353-sch90
Short dwell-time and poor penetration of the bladder permeability barrier (BP are the main obstacles to intravesical treatments for bladder diseases, and is evidenced by the lack of such therapeutic options on the market. Herein, we demonstrate that by finely tuning the molecular weight of our cationic polymer mucoadhesive nanoparticles, we enhanced our gene transfer, leading to improved adherence and penetrance through the BPB in a safe and efficient manner. Specifically, increasing the polymer molecular weight from 45 kDa
Like
Comment
Share
